TDS Pharm Co (XKRX:464280) COGS-to-Revenue : 0.78 (As of Mar. 2025)

View and export this data going back to 2024. Start your Free Trial

What is TDS Pharm Co COGS-to-Revenue?

TDS Pharm Co's Cost of Goods Sold for the three months ended in Mar. 2025 was ₩4,101 Mil. Its Revenue for the three months ended in Mar. 2025 was ₩5,277 Mil.

TDS Pharm Co's COGS to Revenue for the three months ended in Mar. 2025 was 0.78.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. TDS Pharm Co's Gross Margin % for the three months ended in Mar. 2025 was 22.30%.

TDS Pharm Co COGS-to-Revenue Historical Data

The historical data trend for TDS Pharm Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TDS Pharm Co COGS-to-Revenue Chart

TDS Pharm Co Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

COGS-to-Revenue

0.82

0.80

0.76

0.74

0.72

TDS Pharm Co Quarterly Data
	Dec20	Dec21	Dec22	Mar23	Sep23	Dec23	Mar24	Sep24	Dec24	Mar25
COGS-to-Revenue	Get a 7-Day Free Trial					0.73	0.74	0.71	0.74	0.78

TDS Pharm Co COGS-to-Revenue Calculation

TDS Pharm Co's COGS to Revenue for the fiscal year that ended in Dec. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	19796.849	/	27518.776
	=	0.72

TDS Pharm Co's COGS to Revenue for the quarter that ended in Mar. 2025 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	4100.54	/	5277.437
	=	0.78

TDS Pharm Co (XKRX:464280) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

TDS Pharm Co's Gross Margin % for the three months ended in Mar. 2025 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	4100.54 / 5277.437
	=	22.30 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

TDS Pharm Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of TDS Pharm Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

TDS Pharm Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » TDS Pharm Co Ltd (XKRX:464280) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

253 Pangyo-ro, Pangyo Inno Valley, Building C, Room 403, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13486

Website

https://www.tdspharm.com

TDS Pharm Co Ltd is engaged in the development and manufacturing of the Transdermal Drug Delivery System (TDDS), which is growing as a high-growth business sector in the field of drug delivery systems (DDS). The Transdermal Drug Delivery System (TDDS) is a drug delivery system that delivers drugs through the skin at a controlled speed. It has the advantages of increasing patient compliance with drugs, maximizing efficacy and effectiveness, such as minimizing side effects in the liver and digestive organs, controlling absorption rate, controlling discontinuation, controlling effective blood concentration, and enabling long-term continuous administration, and reducing burden compared to oral and injection drugs.

TDS Pharm Co Headlines

No Headlines